Cargando…

Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons

Glycogen synthase kinase-3β (GSK-3β) has been shown to attenuate DNA damage in nerve cells, thereby enhancing neuronal survival under pathological conditions; however, the underlying mechanism remains unclear. An in vitro serum-starvation retinal neuron model and in vivo ischemia/reperfusion retina...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Lai, Zhi-Peng, Chen, Pei, Ying, Yang, Zhuang, Jing, Yu, Ke-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7896226/ https://www.ncbi.nlm.nih.gov/pubmed/32859805 http://dx.doi.org/10.4103/1673-5374.290913

Ejemplares similares

Corrigendum: Glycogen synthase kinase-3β inhibitor SB216763 promotes DNA repair in ischemic retinal neurons
Publicado: (2021)

Glycogen Synthase Kinase 3 (GSK3) Inhibitor, SB-216763, Promotes Pluripotency in Mouse Embryonic Stem Cells
por: Kirby, Leslie A., et al.
Publicado: (2012)

Long-Lasting Antidepressant Action of Ketamine, but Not Glycogen Synthase Kinase-3 Inhibitor SB216763, in the Chronic Mild Stress Model of Mice
por: Ma, Xian-Cang, et al.
Publicado: (2013)

Lenticular mitoprotection. Part A: Monitoring mitochondrial depolarization with JC-1 and artifactual fluorescence by the glycogen synthase kinase-3β inhibitor, SB216763
por: Brooks, Morgan M., et al.
Publicado: (2013)

Small-Molecule SB216763-Loaded Microspheres Repair Peripheral Nerve Injury in Small Gap Tubulization
por: Rao, Feng, et al.
Publicado: (2019)

Testing Fmr1(KO) Phenotypes in Response to GSK3 Inhibitors: SB216763 versus AFC03127
por: Westmark, Pamela R., et al.
Publicado: (2021)

SB‐216763, a GSK‐3β inhibitor, protects against aldosterone‐induced cardiac, and renal injury by activating autophagy
por: Zhang, Yi‐De, et al.
Publicado: (2018)

The Effects of Glycogen Synthase Kinase-3beta in Serotonin Neurons
por: Zhou, Wenjun, et al.
Publicado: (2012)

Glycogen Synthase Kinase-3
por: Crouch, Peter, et al.
Publicado: (2011)

In vivo regulation of glycogen synthase kinase 3β activity in neurons and brains
por: Krishnankutty, Ambika, et al.
Publicado: (2017)

Glycogen synthase kinase 3β in tumorigenesis and oncotherapy
por: He, Rui, et al.
Publicado: (2020)

Association of glycogen synthase kinase-3β with Parkinson’s disease (Review)
por: LI, DA-WEI, et al.
Publicado: (2014)

Glycogen Synthase Kinase 3 Regulates the Genesis of Displaced Retinal Ganglion Cells3
por: Kisseleff, Elena, et al.
Publicado: (2021)

Enhancement of Glycosaminoglycan-Rich Matrix Production in Human Marrow-Derived Mesenchymal Stem Cell Chondrogenic Culture by Lithium Chloride and SB216763 Treatment
por: Baghaban Eslaminejad, Mohamadreza, et al.
Publicado: (2011)

PM(2.5) Exposure-Linked Mitochondrial Dysfunction Negates SB216763-Mediated Cardio-Protection against Myocardial Ischemia–Reperfusion Injury
por: Sivakumar, Bhavana, et al.
Publicado: (2023)

Interactomes of Glycogen Synthase Kinase-3 Isoforms
por: Cormier, Kevin W., et al.
Publicado: (2023)

The role of glycogen synthase kinase-3β in glioma cell apoptosis induced by remifentanil
por: Xu, Jing, et al.
Publicado: (2013)

Glycogen Synthase Kinase 3β in Cancer Biology and Treatment
por: Domoto, Takahiro, et al.
Publicado: (2020)

Control of neuronal ion channel function by glycogen synthase kinase-3: new prospective for an old kinase
por: Wildburger, Norelle C., et al.
Publicado: (2012)

Ischemic postconditioning enhances glycogen synthase kinase-3β expression and alleviates cerebral ischemia/reperfusion injury★
por: Zhao, Bo, et al.
Publicado: (2012)

Sustained release of a highly specific GSK3β inhibitor SB216763 in the PCL scaffold creates an osteogenic niche for osteogenesis, anti-adipogenesis, and potential angiogenesis
por: Gong, Weimin, et al.
Publicado: (2023)

Role of Glycogen Synthase Kinase-3β in APP Hyperphosphorylation Induced by NMDA Stimulation in Cortical Neurons
por: Ploia, Cristina, et al.
Publicado: (2010)

Inhibition of glycogen synthase kinase 3β prevents NSAID-induced acute kidney injury
por: Bao, Hao, et al.
Publicado: (2012)

Small molecules targeting glycogen synthase kinase 3 as potential drug candidates for the treatment of retinitis pigmentosa
por: Marchena, Miguel, et al.
Publicado: (2017)

Aberrant glycogen synthase kinase 3β in the development of pancreatic cancer
por: Shimasaki, Takeo, et al.
Publicado: (2012)

Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD
por: Ngkelo, Anta, et al.
Publicado: (2015)

Glycogen synthase kinase 3β in Toll-like receptor signaling
por: Ko, Ryeojin, et al.
Publicado: (2016)

Amaryllidaceae Alkaloids as Potential Glycogen Synthase Kinase-3β Inhibitors
por: Hulcová, Daniela, et al.
Publicado: (2018)

Glycogen synthase kinase-3β: a promising candidate in the fight against fibrosis
por: Zheng, Hanxue, et al.
Publicado: (2020)

Hydrosulfide attenuates acute myocardial ischemic injury through the glycogen synthase kinase-3β/β-catenin signaling pathway
por: GE, NING, et al.
Publicado: (2016)

Glycogen Synthase Kinase-3β, NF-κB Signaling, and Tumorigenesis of Human Osteosarcoma
por: Tang, Qing-Lian, et al.
Publicado: (2012)

Modulation of glycogen synthase kinase-3β following TRAIL combinatorial treatment in cancer cells
por: Santha, Sreevidya, et al.
Publicado: (2016)

Glycogen Synthase Kinase-3 in the Etiology and Treatment of Mood Disorders
por: Jope, Richard Scott
Publicado: (2011)

Glycogen Synthase Kinase-3 is an Intermediate Modulator of Serotonin Neurotransmission
por: Polter, Abigail M., et al.
Publicado: (2011)

Glycogen Synthase Kinase-3 Is Required for Efficient Dictyostelium Chemotaxis
por: Teo, Regina, et al.
Publicado: (2010)

Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases
por: Marosi, Mate, et al.
Publicado: (2022)

The role of glycogen synthase kinase 3 beta in neurodegenerative diseases
por: Yu, Honglu, et al.
Publicado: (2023)

Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3β is implicated in the treatment of cervical carcinoma
por: Zhang, Yuan, et al.
Publicado: (2010)

Regulation of persistent sodium currents by glycogen synthase kinase 3 encodes daily rhythms of neuronal excitability
por: Paul, Jodi R., et al.
Publicado: (2016)

Glycogen Synthase Kinase-3β Is a Negative Regulator of Cardiomyocyte Hypertrophy
por: Haq, Syed, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_1m8p4f3u65shl0qbadsnrqan0l